109451
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
四川宜宾地区血流感染病原菌分布及耐药性分析
Authors Zhou X, Hu R, Xia Y, Li X, Nie S, Li T, Chen C, Qi B, Li W
Received 29 July 2025
Accepted for publication 9 October 2025
Published 11 October 2025 Volume 2025:18 Pages 5295—5306
DOI https://doi.org/10.2147/IDR.S556913
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Hazrat Bilal
Xiangtian Zhou,* Rong Hu,* Yuehua Xia, Xu Li, Shuangquan Nie, Tindong Li, Chao Chen, Bangdong Qi, Wenquan Li
Department of Infectious Diseases, Second People’s Hospital of Yibin City, Yibin, Sichuan, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Wenquan Li, Department of Infectious Diseases, Second People’s Hospital of Yibin City, Yibin, Sichuan Province, 644000, People’s Republic of China, Email ybeygrzx@163.com
Purpose: To determine the distribution and antimicrobial resistance patterns of bloodstream infection (BSI) pathogens in Yibin, China, and to provide evidence for optimizing local empirical therapy and infection-control strategies.
Methods: A retrospective study was performed on 4431 non-duplicate bloodstream isolates recovered from 32569 patients at Yibin Second People’s Hospital between January 2017 and December 2024. Organisms were identified and tested for antimicrobial susceptibility by Kirby-Bauer disk diffusion or VITEK-2 Compact. Antibiotic resistance to selected agents (eg polymyxins, vancomycin) were evaluated by broth micro-dilution and analysed based on CLSI M100-S34.
Results: Gram-negative bacteria became the dominant isolates (51.4%), with their proportion significantly increasing during the study period. The main pathogens were Escherichia coli (27.4%), coagulase-negative Staphylococci (CoNS, 20.4% combined), and Klebsiella pneumoniae (9.7%). Among Enterobacteriaceae, ESBL-producing E. coli was highly prevalent (63.6%), and carbapenem-resistant K. pneumoniae (CRKP) emerged at 8.7%. Critically, Acinetobacter baumannii showed extensive drug resistance, with carbapenem resistance at 62.1– 65.3% and carbapenem-resistant isolates (CRAB) exhibiting > 70% resistance to most tested agents. Among Gram-positive pathogens, while methicillin resistance in CoNS was high (78%), no resistance to vancomycin or linezolid was detected in any Staphylococcus or Enterococcus isolate.
Conclusion: Bloodstream infections in Yibin are increasingly dominated by Gram-negative organisms, with ESBL-producing E. coli and multidrug-resistant A. baumannii posing critical therapeutic challenges. Continuous local surveillance and antimicrobial stewardship are imperative to optimize empirical therapy and improve patient outcomes.
Keywords: blood flow infection, pathogenic bacteria, antibacterial, drug resistance
Department of Infectious Diseases, Second People’s Hospital of Yibin City, Yibin, Sichuan, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Wenquan Li, Department of Infectious Diseases, Second People’s Hospital of Yibin City, Yibin, Sichuan Province, 644000, People’s Republic of China, Email ybeygrzx@163.com
Purpose: To determine the distribution and antimicrobial resistance patterns of bloodstream infection (BSI) pathogens in Yibin, China, and to provide evidence for optimizing local empirical therapy and infection-control strategies.
Methods: A retrospective study was performed on 4431 non-duplicate bloodstream isolates recovered from 32569 patients at Yibin Second People’s Hospital between January 2017 and December 2024. Organisms were identified and tested for antimicrobial susceptibility by Kirby-Bauer disk diffusion or VITEK-2 Compact. Antibiotic resistance to selected agents (eg polymyxins, vancomycin) were evaluated by broth micro-dilution and analysed based on CLSI M100-S34.
Results: Gram-negative bacteria became the dominant isolates (51.4%), with their proportion significantly increasing during the study period. The main pathogens were Escherichia coli (27.4%), coagulase-negative Staphylococci (CoNS, 20.4% combined), and Klebsiella pneumoniae (9.7%). Among Enterobacteriaceae, ESBL-producing E. coli was highly prevalent (63.6%), and carbapenem-resistant K. pneumoniae (CRKP) emerged at 8.7%. Critically, Acinetobacter baumannii showed extensive drug resistance, with carbapenem resistance at 62.1– 65.3% and carbapenem-resistant isolates (CRAB) exhibiting > 70% resistance to most tested agents. Among Gram-positive pathogens, while methicillin resistance in CoNS was high (78%), no resistance to vancomycin or linezolid was detected in any Staphylococcus or Enterococcus isolate.
Conclusion: Bloodstream infections in Yibin are increasingly dominated by Gram-negative organisms, with ESBL-producing E. coli and multidrug-resistant A. baumannii posing critical therapeutic challenges. Continuous local surveillance and antimicrobial stewardship are imperative to optimize empirical therapy and improve patient outcomes.
Keywords: blood flow infection, pathogenic bacteria, antibacterial, drug resistance